Dr Boreham’s Crucible: Nova Eye’s US vision sharpens as profits come into view

Dr Boreham’s Crucible: Nova Eye’s US vision sharpens as profits come into view

With most of its sales now coming from the US, glaucoma device maker Nova Eye Medical is steering a steady course through global trade turbulence.

Rise and Shine: Everything you need to know before the ASX opens

Rise and Shine: Everything you need to know before the ASX opens

Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.

ASX October Winners: Modest gains for ASX as Mount Ridley soars 967pc

ASX October Winners: Modest gains for ASX as Mount Ridley soars 967pc

The ASX 200 rose 0.39% in October with seven of 11 sectors gaining as Mount Ridley Mines soared 967%.

Up, Up, Down, Down: Gold hit a record but will we look back on October as lithium’s turning point?

Up, Up, Down, Down: Gold hit a record but will we look back on October as lithium’s turning point?

Lithium may have turned a corner in October, while gold and copper both touched record highs before late pullbacks.

ASX Quarterly Medtech Wrap: Strong growth, fresh capital and key milestones

ASX Quarterly Medtech Wrap: Strong growth, fresh capital and key milestones

Control Bionics, PainChek, Optiscan and EMVision are among ASX health companies reporting quarterly results.

Locksley Resources’ US$191m EXIM letter of interest validates focus on US critical minerals production